Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 6, 2012, Pages 2401-2409

  Kohles, Nikolaus ^a   Nagel, Dorothea ^b   Jüngst, Dietrich ^b   Stieber, Petra ^b   Holdenrieder, Stefan ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; DEOXYRIBONUCLEASE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN RECEPTOR; TUMOR MARKER;

AGED; ARTICLE; BLOOD; CANCER STAGING; CHEMOEMBOLIZATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DEOXYRIBONUCLEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HMGB1 PROTEIN; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 85027938747     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0504-2     Document Type: Article

References (0)